3 OPV procurement - Nov 2010 to Feb 2012 Total : million dosesDomestic procurement necessitated in order to meet shortfall due to inability by RITES to procure required quantity of vaccine
4 Procurement status : 2011 vs 2012 tOPV for NIDsProcurement status : vs 2012Jan to Mar 2011Jan to Apr 2012Total : 471 millionTotal : 450 million
5 tOPV procurement – NIDs 2012 Requirement of tOPV for Jan/Feb 2012 NIDs: 450 mn dosesIndent for 450 mn doses placed through RITES in Jan 2011RITES secured only million doses as shown below:Thus, a shortfall of mn doses for the 2 NIDsCompanyQty offeredRemarks1Haffkine109.3783.58 mn for Jan 12 and mn for Feb 122Panacea184.70Unable to supply as temporarily withdrawn WHO prequalification status.3Sanofi127.62Technically disqualified due to short shelf life.
6 tOPV Vaccine for NID contd… Domestic procurement initiated to meet the shortfall of million dosesStill a shortfall of for 2 NIDs taking into account the availability through RITES and Domestic procurement2nd tender floated to meet shortfall – vaccine available only in April 2012tOPV availability (in million doses)S NoCompanyQty offeredRemarks1Bharat12550 for Jan & 75 for Feb2Haffkine10919 by Feb & 90 by Mar3Panacea13.4Not accepted on tech groundTotal available234
7 tOPV Vaccine for NID 2012 - Summary Vaccine availability:Shortfall of 47% for Jan & 50% for Feb NID.Available supplies for both NIDs combined to conduct 1st NID on 19 February 2012Since part of vaccine requirement for 2nd NID available only by 5 April 2012, 2nd NID planned on 15 April 2012S.No.CompanyQuantityRemarksJanuary 2012 Round1Haffkine69.65RITES2Bharat Biotech50DomesticTotal Vaccine available for Jan119.65February 2012 Round39.775Total Vaccine available for Feb114.7
8 SIA calendar – 2012 revised as below NIDtOPVNIDtOPVSNID (bOPV)Endemic & risk statesSNID (bOPV)Endemic & risk statesSNID (bOPV)Endemic & risk statesSNID (bOPV)Endemic & risk statesJanFebMarAprMayJunSNID round conducted on 15 January 2012 using buffer stock of bOPVSNID planned on 18 March 2012 with bOPV88
9 bOPV – supply status Nov 2010 to Mar 2012 Apr 2012 to Jun 2012 Total vaccine procured : mnTotal vaccine required :340 mn
10 bOPV procurement for SNIDs – Quarter 2, 2012 Summary 340 million doses of bOPV requiredRITES has offered only 238 million dosesOf these, order placed for million dosesHowever only mn doses available during May and June, balance available between August & October 2012Domestic procurement to meet shortfall
11 Key Issues Non- availability of required quantity of polio vaccine Committed supplies not available as per scheduled timelineBuffer stock used frequently to manage the gap in supply for conducting SNID/NID resulting in very low buffer stock and supply schedule not adequate to build up bufferLast minute intimation of inability to supply committed vaccine by manufacturersLimited manufacturers of tOPV and even lesser for bOPVbOPV vaccine for May and June SNID not fully secured
Your consent to our cookies if you continue to use this website.